QuantHealth, an AI-focused clinical trial design company based out of Tel Aviv, has announced the completion of more than 100 simulated clinical trials, reporting an 85% accuracy rate. The company, which received $17 million in a Series A funding round with backing from Accenture, aims to chip away at the steep costs and stubborn timelines…
How BMS aims to close the LGBTQ+ data gap in clinical trials
In terms of treatment outcomes, the LGBTQ+ community continues to face significant disparities. For instance, a recent study in JAMA on breast cancer outcomes reported that those from sexual and gender minority groups were more likely to face delays in diagnosis. LGBTQ+ patients were also more likely to decline oncologist-recommended therapies while experiencing a three-fold…
Survey: Wielding AI magic in clinical trials requires a master’s touch
eClinical’s Industry Outlook 2024 report highlights a significant acceleration in AI/ML adoption for clinical trials. Over half of professionals (53%) in functions like clinical operations, data management, and biometrics now see these technologies as central to streamlining trials by 2024, surpassing the emphasis on automation that dominated last year. Despite this hype cycle, a core…
Interview: MIT legend Robert Langer backs Lindus Health’s ‘anti-CRO’ strategy
Biotech startup Lindus Health just made a big splash by adding MIT professor and Moderna co-founder Robert Langer, Sc.D., to its advisory board. Lindus aims to shake up the world of clinical trials with its “anti-CRO” approach that promises faster and more reliable trials for life sciences companies. The addition of Langer, described as the…